# Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

> **NCT01786707** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rodolfo Alejandro** · enrollment: 2 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Autologous stem cells
- **OTHER:** Hyperbaric oxygen therapy
- **DRUG:** Insulin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01786707
- **Lead sponsor:** Rodolfo Alejandro
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-03
- **Final completion:** 2013-03
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01786707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01786707, "Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01786707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*